Less Ads, More Data, More Tools Register for FREE

Pin to quick picksECM.L Regulatory News (ECM)

  • There is currently no data for ECM

Trading Update

5 Feb 2018 07:14

RNS Number : 8852D
Electrocomponents PLC
05 February 2018
 

 

Electrocomponents plc today issues a trading update for the four-month period to 31 January 2018.

 

Underlying revenue growth(1)

Region

Q1 to June 2017

Q2 to Sept 2017

4 months to 31 Jan 2018

 

Northern Europe

 

10%

 

12%

13%

Southern Europe

10%

12%

11%

Central Europe

11%

14%

17%

Total Europe

10%

13%

13%

Asia Pacific

18%

17%

22%

The Americas

16%

15%

12%

Group

13%

14%

14%

 

Our strong underlying revenue (1) performance in H1 has continued into the first four months of H2. The market backdrop remains positive and we continue to execute well with improvements in areas such as customer experience, digital and sales effectiveness driving further market share gains.

· In the four months to 31 January 2018, Group underlying revenue growth remained strong at 14%, with all of our five regions continuing to see double-digit underlying revenue growth.

o Strong momentum in digital with 15% underlying revenue growth in the period reflecting success with our digital marketing strategy and improved online experience.

o A further acceleration in underlying revenue growth at RS Pro, our own-brand business, which grew at 14% during the period (+10% in H1).

· We remain on track to deliver stable gross margin for the full year to March 2018.

· At the end of this financial year we will have completed the first phase of the Performance Improvement Plan and delivered cumulative annualised savings of £30 million. We are currently examining new initiatives to further simplify the way we do business and generate efficiency.

 

Lindsley Ruth, Chief Executive Officer, commented

"Our performance year to date has been pleasing and we are confident of delivering strong progress in the current financial year. The first phase of the Performance Improvement Plan is now complete, but we still believe we have a significant further opportunity to improve efficiency and reduce complexity allowing continued strong growth at higher operating margins. We remain excited by the opportunity for growth and improvement."

 

LEI: 549300KVXDURRKVW7R37

 

Enquiries:

David Egan

Group Finance Director

0207 239 8400

Polly Elvin

Investor Relations and Corporate PR

0207 239 8427

Martin Robinson/David Allchurch

Tulchan Communications

0207 353 4200

 

Notes:

1. Revenue growth rates, unless otherwise stated, are adjusted for trading days and currency movements ("underlying revenue growth/decline").

2. During the year to March 2018 we expect to see around a £24 million adverse impact on revenue from fewer trading days compared with FY 2017. In the year to March 2019 we expect to see a positive impact of around £9 million on revenue from additional trading days compared with FY 2018.

3. Our profit remains sensitive to movements in exchange rates on translation of overseas profits. The average H1 exchange rates for Euro and US $ respectively were €1.14 and $1.29. Ten months to 31 January average spot rates for Euro and US $ respectively are €1.13 and $1.31. Assuming 31 January spot rates continue for the balance of the year our average exchange rates for Euro and US $ for the year would be €1.13 and $1.32. Every 1 cent movement in the Euro will have a circa £1.2 million impact on profit. Every 1 cent movement in US $ will have a circa £0.4 million impact on profit.

 

 

 

Electrocomponents plc - Conference Call Dial in Instructions

Date:

Monday 5 February

UK Time:

08.00h call

Telephone number:

+44 (0) 1452 541003

PIN:

9377237

Chairman:

Lindsley Ruth

Electrocomponents plc - Replay Dial in Instructions (available until Monday 12 February)

Telephone number:

+44 (0) 1452 550000

PIN:

9377237

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTUVABRWAAURRR
Date   Source Headline
7th Mar 20173:43 pmRNSDirector Declaration
1st Mar 201712:28 pmRNSTotal Voting Rights
15th Feb 20172:48 pmRNSDirector/PDMR Shareholding
10th Feb 20177:00 amRNSTrading update
1st Feb 20172:15 pmRNSHolding(s) in Company
1st Feb 201710:37 amRNSBlock listing Interim Review
31st Jan 201710:33 amRNSTotal Voting Rights
23rd Jan 201711:59 amRNSHolding(s) in Company
13th Jan 20174:01 pmRNSNotice of trading update
3rd Jan 201711:41 amRNSTotal Voting Rights
21st Dec 20167:00 amRNSDirectorate Change
9th Dec 201610:28 amRNSHolding(s) in Company
1st Dec 201611:12 amRNSTotal Voting Rights
18th Nov 20167:00 amRNS2017 Half-year Financial Results
14th Nov 201612:37 pmRNSHolding(s) in Company
31st Oct 20161:37 pmRNSTotal Voting Rights
7th Oct 20163:47 pmRNSHolding(s) in Company
4th Oct 20161:25 pmRNSHolding(s) in Company
30th Sep 201610:12 amRNSTotal Voting Rights
15th Sep 20162:48 pmRNSHolding(s) in Company
15th Sep 20167:00 amRNSTrading Statement
12th Sep 20167:00 amRNSDirectorate Change
1st Sep 201610:19 amRNSTotal Voting Rights
1st Aug 20169:42 amRNSBlock listing Interim Review
29th Jul 20162:50 pmRNSDirector/PDMR Shareholding
29th Jul 201611:35 amRNSTotal Voting Rights
22nd Jul 20169:23 amRNSDirector/PDMR Shareholding
20th Jul 201612:43 pmRNSResult of AGM
20th Jul 20167:00 amRNSDirectorate Change
20th Jul 20167:00 amRNSTrading Statement
5th Jul 201612:06 pmRNSNotice of Trading Update
30th Jun 201611:28 amRNSTotal Voting Rights
27th Jun 201611:39 amRNSDirector/PDMR Shareholding
23rd Jun 20161:04 pmRNSDirector/PDMR Shareholding
20th Jun 201610:40 amRNSDirector/PDMR Shareholding
16th Jun 20169:44 amRNSAnnual Financial Report
31st May 201610:45 amRNSTotal Voting Rights
23rd May 201610:40 amRNSHolding(s) in Company
19th May 20167:00 amRNSFinal Results
29th Apr 201610:00 amRNSTotal Voting Rights
5th Apr 20167:00 amRNSTrading Update
1st Apr 20167:00 amRNSTotal Voting Rights
31st Mar 20167:00 amRNSDirectorate Change
29th Mar 201611:34 amRNSHolding(s) in Company
18th Mar 201612:03 pmRNSDirector/PDMR Shareholding
18th Mar 20169:53 amRNSNotice of trading update
14th Mar 201611:37 amRNSDirector/PDMR Shareholding
1st Mar 20169:22 amRNSTotal Voting Rights
10th Feb 20167:00 amRNSTrading Statement
1st Feb 201610:41 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.